Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Harvard Ave Acquisition Corporation Announces Closing of $145,000,000 Initial Public Offering
GlobeNewswire, Inc.
New York, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Ave Acquisition Corporation (Nasdaq: HAVAU) (the “Company”) announced today the closing of its initial public offering of 14,500,000 units at $10.00 per unit.
Harvard Ave Acquisition Corporation Announces Pricing of $145,000,000 Initial Public Offering
GlobeNewswire, Inc.
New York, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Harvard Ave Acquisition Corporation (Nasdaq: HAVAU) (the “Company”) announced today the pricing of its initial public offering of 14,500,000 units at $10.00 per unit.
Rising Dragon Acquisition Corp. Announces Postponement of the Extraordinary General Meeting to November 20, 2025 and Extension of Redemption Request Deadline
GlobeNewswire, Inc.
SHANXI, CHINA, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rising Dragon Acquisition Corp. (NASDAQ: RDAC) (the “Company”), a blank check company, today announced that its previously announced Extraordinary General Meeting of shareholders (the “Extraordinary...
Responses to the SEC’s Concept Release on Foreign Private Issuer Eligibility
The Harvard Law School Forum on Corporate Governance
On June 4, 2025, the U.S. Securities and Exchange Commission (the “SEC”) published a Concept Release on Foreign Private Issuer Eligibility (the “Concept Release”) soliciting public comment on proposed changes to the definition of foreign private...
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
GlobeNewswire, Inc.
Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of 50,000,000 units at $10.00 per unit.
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
GlobeNewswire, Inc.
Fort Lauderdale, FL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) announced today the pricing yesterday of its initial public offering of 50,000,000 units at $10.00 per unit.
Sign up for:
Cayman Islands Sun
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.